We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Global Health | LSE:GHP | London | Ordinary Share | GB00B23TTS84 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 115.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 4228W Global Health Partner PLC 11 June 2008 11 June 2008 Global Health Partner ("GHP" or "the Company") Corporate Reorganisation and Outcome of AGM Corporate Reorganisation The Board of GHP announces that it is considering the possibility of de-listing the Company from AIM and re-listing on the OMX Nordic Exchange in Stockholm ("the Nordic Exchange Stockholm"). This move would include a capital reorganisation by way of a scheme of arrangement under part 26 of the Companies Act 2006 whereby shares in GHP would be exchanged for shares in a newly incorporated Swedish domiciled Newco (the "Reorganisation"). The Reorganisation would be conditional upon shareholder approval, UK court approval (with regards to the scheme of arrangement and associated reduction of share capital) and approval from the Nordic Exchange Stockholm (with regards to the re-listing). The Board of GHP is considering a reorganisation whereby the existing shareholding structure in GHP will mirror the new shareholdings structure of Newco. The underlying assets in the Swedish Newco would remain the same as in GHP when the scheme becomes effective. Shareholders would hold the same shareholding and voting rights in Newco as they hold in GHP on the date prior to the scheme becoming effective. There would be no cash consideration offered to shareholders of GHP. Based on these points, the Takeover Panel has confirmed that the Takeover Code would not apply to this transaction. Newco's registered office would be in Sweden and the company would be listed on the Nordic Exchange Stockholm. Accordingly, after the Reorganisation, shareholders of Newco would not be afforded the protection of the Takeover Code. The Newco shares would be expected to start trading on the Nordic Exchange Stockholm within 14 days of being de-listed from AIM. In connection with the start of trading on Nordic Exchange Stockholm, Newco may carry out a placing of new shares, in order to raise further capital to continue the GHP Group's acquisition strategy and increase liquidity in the Newco shares. The Board considers that the move would offer a number of benefits to GHP and its shareholders, including: * Access to the Scandinavian Capital Markets' natural investor base for GHP, as the majority of the Company's operations and senior management team are based in Sweden * An anticipated reduction in listed public company administration costs of Nordic Exchange Stockholm compared with AIM * The move of GHP's corporate headquarters to Gothenburg, Sweden, where the Company's operations are focussed The Board intends to seek a listing of the Company on either the main market of the Nordic Exchange Stockholm or on the secondary exchange, First North. The Board intends to make a final decision on whether to recommend the Reorganisation during July 2008. If it decides to proceed a further announcement will be made following which a Scheme of Arrangement circular, prepared under part 26 of the Companies Act 2006 will be circulated to all shareholders. Subject to shareholder and court approval, the Board anticipates - based on the current best estimate - that the Reorganisation will be completed by the last quarter of 2008. Further, the Company will publish its interim report for the six months ended 30 June 2008, on 21 July 2008. Outcome of AGM Further to the announcement of 9 May 2008 in connection with the Company's annual report and accounts for the year ended 31 December 2007, and the annual general meeting dated June 9, 2008 ("AGM"), the Company also announces the outcome of the AGM. At the AGM, the ordinary resolution to approve the Company's annual report and accounts for the year ended 31 December 2007 was passed, together with all other resolutions of the AGM included in the notice to shareholders of 9 May 2008 (the "Notice"). CONTACTS: Per Batelson, GHP Chief Executive: 00-46-705-955700 or 00- 46- 31- 712- 5302 James Thornton, GHP Company Secretary: 0207-665-1833 Ivonne Cantu / Elizabeth Bowman, Cenkos Securities Plc 0207-397-8928 This information is provided by RNS The company news service from the London Stock Exchange END MSCURABRWVRNAAR
1 Year Global Health Chart |
1 Month Global Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions